| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/28/2011 | WO2011090690A1 Sorghum fertility restorer genotypes and methods of marker-assisted selection |
| 07/28/2011 | WO2011090351A2 Diagnostic method and diagnosing kit for prostatitis |
| 07/28/2011 | WO2011090297A2 Human adult stem cell for expressing anti-mdm2, and use thereof |
| 07/28/2011 | WO2011090272A2 OsMPT GENE MODIFYING PLANT ARCHITECTURE (PLANT SHAPE) AND INCREASING YIELD, AND USE THEREOF |
| 07/28/2011 | WO2011090159A1 Probe reagent for measurement of protein decomposition activity |
| 07/28/2011 | WO2011090154A1 Target sequence amplification method, polymorphism detection method, and reagents for use in the methods |
| 07/28/2011 | WO2011090091A1 Method for determination whether or not cell population is suitable for foreign gene transfer for the purpose of preparation of adipocytes for gene therapy application |
| 07/28/2011 | WO2011090065A1 Peptide vaccine |
| 07/28/2011 | WO2011090054A1 Nadh oxidase mutant having improved stability and use thereof |
| 07/28/2011 | WO2011089953A1 Foreign gene transfer method by electroporation technique |
| 07/28/2011 | WO2011089937A1 Method for uniform amplification of nucleic acid and highly sensitive detection method |
| 07/28/2011 | WO2011089574A2 Methods of generating modified polynucleotide libraries and methods of using the same for directed protein evolution |
| 07/28/2011 | WO2011089541A1 Methods for intracellular delivery of nucleic acids |
| 07/28/2011 | WO2011089527A1 Methods and compositions for displaying a poypeptide on a yeast cell surface |
| 07/28/2011 | WO2011089299A1 Methods and compositions for identifying embryotoxic compounds |
| 07/28/2011 | WO2011089271A1 An inducible baculovirus system in insect cells |
| 07/28/2011 | WO2011089152A1 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
| 07/28/2011 | WO2011089021A1 Methods for manufacturing plant cell walls comprising chitin |
| 07/28/2011 | WO2011060065A3 Instillation of liposomal formulation of sirna and antisense oligonucleotides |
| 07/28/2011 | WO2011058029A9 Plants having enhanced yield-related traits and a method for making the same |
| 07/28/2011 | WO2011054939A3 Compositions and methods for inhibiting expression of kif10 genes |
| 07/28/2011 | WO2011053764A8 Methods for the biosynthesis of taurine or hypotaurine in cells |
| 07/28/2011 | WO2011050281A3 A method of controlling plant growth and architecture by controlling expression of gibberellin 2-oxidase |
| 07/28/2011 | WO2011044541A3 Identification of micrornas (mirnas) in fecal samples as biomarkers for gastroenterological cancers |
| 07/28/2011 | WO2011038160A3 Compositions and methods for silencing genes expressed in cancer |
| 07/28/2011 | WO2011037802A3 Methods and compositions for detection of nucleic acids based on stabilized oligonucleotide probe complexes |
| 07/28/2011 | WO2011036450A3 Splice variants |
| 07/28/2011 | WO2011035244A3 Tctex-1 regulatory sequence region as stem cell marker |
| 07/28/2011 | WO2011035012A3 Methods and compositions for diagnosing heart failure |
| 07/28/2011 | WO2011028980A3 Markers for detecting cancer cells |
| 07/28/2011 | WO2011025310A9 Attenuated salmonella variant strain resulting from the genetic transformation of adhesin from pathogenic pig escherichia coli and a vaccine composition comprising the same for preventing and treating pathogenic colibacillosis and salmonellosis in pigs |
| 07/28/2011 | WO2011022590A3 Heavy metal remediation system |
| 07/28/2011 | WO2011022413A3 Reprogramming a cell by activation of the endogenous transcription factor network |
| 07/28/2011 | WO2011017516A3 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 07/28/2011 | WO2011005580A3 Adult animals generated from induced pluripotent cells |
| 07/28/2011 | WO2011005554A3 Recombinant ethanologenic bacteria |
| 07/28/2011 | WO2011002239A9 Microvesicles derived from nucleated, mammalian cells and use thereof |
| 07/28/2011 | US20110185454 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 07/28/2011 | US20110185453 Production of syringyl lignin in gymnosperms |
| 07/28/2011 | US20110185452 Compositions and methods for improving plants |
| 07/28/2011 | US20110185450 Plant 1-deoxy-d-xylulose 5-phosphate reductoisomerase |
| 07/28/2011 | US20110185449 Modified Xylan Production |
| 07/28/2011 | US20110185447 Lettuce cultivar 51-0804523-b |
| 07/28/2011 | US20110185446 Soybean Cultivar 3955412 |
| 07/28/2011 | US20110185444 Polynucleotide and polypeptide sequences associated with herbicide tolerance |
| 07/28/2011 | US20110185442 Method of generating transgenic organisms using transposons |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184145 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 07/28/2011 | US20110184051 Pharmacological applications of mitochondrial dna assays |
| 07/28/2011 | US20110184050 Methods and means for treating dna repeat instability associated genetic disorders |
| 07/28/2011 | US20110184049 Liver-specific nucleic acid regulatory elements and methods and use thereof |
| 07/28/2011 | US20110184048 Uses and Compositions Comprising miRNAs |
| 07/28/2011 | US20110184047 Rnai modulation of scap and therapeutic uses thereof |
| 07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 07/28/2011 | US20110184045 Silencng and rig-i activation by dual function oligonucleotides |
| 07/28/2011 | US20110184043 Inhibition of angiogenesis |
| 07/28/2011 | US20110183931 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 07/28/2011 | US20110183923 Peptide antagonists of zonulin and methods for use of the same |
| 07/28/2011 | US20110183917 P53 Activator Peptides |
| 07/28/2011 | US20110183916 Apo-2 Ligand |
| 07/28/2011 | US20110183909 Treatment of Mood and Anxiety Disorders |
| 07/28/2011 | US20110183908 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 07/28/2011 | US20110183907 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 07/28/2011 | US20110183897 Variant activin receptor polypeptides |
| 07/28/2011 | US20110183865 Lipoxygenase |
| 07/28/2011 | US20110183417 Polyamides for nucleic acid delivery |
| 07/28/2011 | US20110183412 Alteration of fc-fusion protein serum half-lives by mutagenesis |
| 07/28/2011 | US20110183402 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 07/28/2011 | US20110183401 Kappa-Carrageenase And Kappa-Carrageenase-Containing Compositions |
| 07/28/2011 | US20110183399 Maize Cellulose Synthases and Uses Thereof |
| 07/28/2011 | US20110183396 Production and use of yeast having increased cellulose hydrolysis ability |
| 07/28/2011 | US20110183388 Extracellular Polyhydroxyalkanoates Produced By Genetically Engineered Microorganisms |
| 07/28/2011 | US20110183387 New Mutant Yeast Strains Capable of Accumulating a Large Quantity of Lipids |
| 07/28/2011 | US20110183384 Recombinant bacteria for producing deoxyviolacein and uses thereof |
| 07/28/2011 | US20110183377 Methods, systems and reagents for improved immunodetection |
| 07/28/2011 | US20110183376 Novel anti-igf-ir antibodies and uses thereof |
| 07/28/2011 | US20110183374 Thiopeptide precursor protein, gene encoding it and uses thereof |
| 07/28/2011 | US20110183360 Antibodies to clostridium difficile spores and uses thereof |
| 07/28/2011 | US20110183359 Methods for detecting modulators of cytokine receptor zalpha11 |
| 07/28/2011 | US20110183335 Methods and compositions for perioperative genomic profiling |
| 07/28/2011 | US20110183329 Protein phosphatase-1 inhibitor-1 polymorphism and methods of use |
| 07/28/2011 | US20110182944 Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein |
| 07/28/2011 | US20110182942 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
| 07/28/2011 | US20110182938 Influenza nucleic acid molecules and vaccines made therefrom |
| 07/28/2011 | US20110182936 Influenza hemagglutinin and neuraminidase variants |
| 07/28/2011 | US20110182933 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182932 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182927 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 07/28/2011 | US20110182923 Novel group b streptococcus antigens |
| 07/28/2011 | US20110182920 Identification of a novel cysteine-rich cell penetrating peptide |
| 07/28/2011 | US20110182908 Diagnostics and Therapeutics for Macular Degeneration-Related Disorders |
| 07/28/2011 | US20110182905 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 07/28/2011 | US20110182904 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 07/28/2011 | US20110182903 Novel soluble cd83 polypeptides, formulations and methods of use |
| 07/28/2011 | US20110182899 Anti-glycoptrotein vi scfv fragment for treatment of thrombosis |
| 07/28/2011 | US20110182896 CLOTTING FACTOR-Fc CHIMERIC PROTEINS TO TREAT HEMOPHILIA |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |